Your browser doesn't support javascript.
loading
Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.
Tsukamoto, Yoshiyuki; Kurogi, Shusaku; Shibata, Tomotaka; Suzuki, Kosuke; Hirashita, Yuka; Fumoto, Shoichi; Yano, Shinji; Yanagihara, Kazuyoshi; Nakada, Chisato; Mieno, Fumi; Kinoshita, Keisuke; Fuchino, Takafumi; Mizukami, Kazuhiro; Ueda, Yoshitake; Etoh, Tsuyoshi; Uchida, Tomohisa; Hanada, Toshikatsu; Takekawa, Mutsuhiro; Daa, Tsutomu; Shirao, Kuniaki; Hironaka, Shuichi; Murakami, Kazunari; Inomata, Masafumi; Hijiya, Naoki; Moriyama, Masatsugu.
  • Tsukamoto Y; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan. tuka@oita-u.ac.jp.
  • Kurogi S; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Shibata T; Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, Oita, Japan.
  • Suzuki K; Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, Oita, Japan.
  • Hirashita Y; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Fumoto S; Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
  • Yano S; Department of Surgery, Oita Nakamura Hospital, Oita, Japan.
  • Yanagihara K; Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Nakada C; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Chiba, Japan.
  • Mieno F; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Kinoshita K; Department of Urology, Faculty of Medicine, Oita University, Oita, Japan.
  • Fuchino T; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Mizukami K; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Ueda Y; Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
  • Etoh T; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Uchida T; Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
  • Hanada T; Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan.
  • Takekawa M; Department of Comprehensive Surgery for Community Medicine, Oita University, Oita, Japan.
  • Daa T; Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, Oita, Japan.
  • Shirao K; Department of Molecular Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Hironaka S; Department of Cell Biology, Oita University Faculty of Medicine, Oita University, Oita, Japan.
  • Murakami K; Division of Cell Signaling and Molecular Medicine, Institute of Medical Sciences, University of Tokyo, Tokyo, Japan.
  • Inomata M; Department of Diagnostic Pathology, Faculty of Medicine, Oita University, Oita, Japan.
  • Hijiya N; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan.
  • Moriyama M; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Oita, Japan.
Lab Invest ; 102(12): 1355-1366, 2022 12.
Article en En | MEDLINE | ID: mdl-35922477
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article